Merck & Co. (MRK) Stock Price, Fundamentals & Analysis

What MRK does

Merck & Co. (MRK) operates as a healthcare company worldwide, developing and selling human health pharmaceuticals across a broad range of therapeutic areas. Its portfolio includes well-known brands such as Keytruda, Gardasil, Januvia, and Isentress, among others. The company is part of the S&P 500 and operates in the Drug Manufacturers - General industry within the Healthcare sector.

Key numbers explained

• The current price of 148.08 USD reflects the latest trading value of one share.
• The trailing P/E ratio of 118.5 compares the share price to the last 12 months of earnings, showing how much investors pay per dollar of recent profit.
• The forward P/E ratio of 15.5 uses expected future earnings, offering a view of valuation based on analyst estimates.
• The dividend yield of 2.25% indicates the annual dividend as a percentage of the current share price.
• The ex-dividend date of Sep 15, 2026 is the cutoff for eligibility to receive the next dividend payment.
• A beta of 0.23 suggests the stock has historically been less volatile than the overall market.
• The 52-week price range of 77,58 – 156,92 shows the lowest and highest traded prices over the past year.
• The price-to-book ratio of 8.72 compares the market price to the company's book value per share.

Recent news

Recent headlines highlight Moderna reaching a new high as its CEO emphasises a future beyond Covid vaccines, and Nvidia-backed AI drug startup gaining AbbVie as a partner ahead of its IPO. Other stories focus on Merck's pipeline and potential re-rating as clinical catalysts approach, alongside broader industry pieces on AbbVie, Pfizer, and Moderna's cancer vaccine ambitions.

What to watch

Investors typically monitor pipeline progress and clinical trial readouts, as new drug approvals can significantly influence the company's outlook. Regulatory decisions, competitive dynamics within the pharmaceutical industry, and broader market conditions also play a role. For peers, you can explore Becton Dickinson (BDX), Bristol Myers Squibb (BMY), or Johnson & Johnson (JNJ) to compare within the healthcare space.